Karyopharm Therapeutics (KPTI) Q4 2024 Earnings

5NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.36
-0.31
-0.25
-0.2

Details

Expected EPS
-0.262857
Actual EPS
-0.26
Surprise EPS
0
Surprise Percent
+1.09%

Description

Karyopharm Therapeutics (KPTI) has reported earnings of -0.26 per share for Q4 2024.

0 Comments

Share your thoughts